Elias Zerhouni

EN Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.

Elias Zerhouni (Arabic: إلياس زرهوني; born April 12, 1951) is an Algerian American radiologist and biomedical engineer who has held leadership roles in academia, government, and the pharmaceutical industry. Zerhouni was a faculty member at Johns Hopkins University School of Medicine and served as the executive vice-dean from 1996 to 2002. He also served as the 15th director of the National Institutes of Health (NIH) from May 2, 2002, to October 31, 2008, under the George W. Bush administration. In 2009, under the Obama administration, he was appointed as one of the first presidential science envoys. He was a senior fellow for the Bill and Melinda Gates Foundation from 2009 to 2010. From January 2011 until his retirement on June 30, 2018, he was the president of Global Research and Development at the pharmaceutical company Sanofi. In October 2020, Zerhouni co-founded ModeX Therapeutics, a privately held biotechnology company focused on immune-based therapies for cancer and infectious diseases. In 2022, ModeX Therapeutics was acquired by OPKO Health, wherein Zerhouni was appointed as the vice-chairman and president.